On October 26, 2022 AI Metrics, an early stage AI-enabled, cancer-imaging radiology software company, reported that it has raised $1.26MM in a bridge financing round (Press release, Metrics, OCT 26, 2022, View Source [SID1234622433]). The round was led by an angel fund and several individual investors, many of them leading radiologists.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

AI Metrics was launched in 2019 by Bob Jacobus, Paige Severino, and radiologist and researcher Dr. Andrew Smith. The company has been developing software to more accurately assess cancer treatment effectiveness — leveraging augmented intelligence to improve radiology workflows and deliver detailed updates of therapy progress to oncologists and patients.

"We are excited to have a mix of existing and new investors support AI Metrics, including several radiologists who are attracted to our promising and innovative technology," said Bob Jacobus, CEO. "AI Metrics expanded its investor base with field experts eager to capitalize on what they see as a breakthrough technology coming to market."

AI Metrics plans to invest in R&D resources to continue its quest to help radiologists deliver improved speed, accuracy, consistency, and clarity of patient condition.